A review of phase 2-3 clinical trial designs (Q1029784): Difference between revisions

@@ Property / cites work @@
+Q4428801
@@ Property / cites work: Q4428801 / rank @@
+Normal rank
@@ Property / cites work @@
+Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Designs for Group Sequential Phase II Clinical Trials
+Normal rank
@@ Property / cites work @@
+One-Sample Multiple Testing Procedure for Phase II Clinical Trials
+Normal rank
@@ Property / cites work @@
+Seamlessly Expanding a Randomized Phase II Trial to Phase III
+Normal rank
@@ Property / cites work @@
+Q4264744
@@ Property / cites work: Q4264744 / rank @@
+Normal rank
@@ Property / cites work @@
+Phase 2 and 3 Combination Designs to Accelerate Drug Development
+Normal rank
@@ Property / cites work @@
+Optimal Dynamic Treatment Regimes
@@ Property / cites work: Optimal Dynamic Treatment Regimes / rank @@
+Normal rank
@@ Property / cites work @@
+Dose-Finding Based on Efficacy-Toxicity Trade-Offs
+Normal rank
@@ Property / cites work @@
+Practical Bayesian Guidelines for Phase IIB Clinical Trials
+Normal rank
@@ Property / cites work @@
+Two-stage selection and testing designs for comparative clinical trials
+Normal rank
@@ Property / cites work @@
+A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
+Normal rank
@@ Property / cites work @@
+Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical Trials
+Normal rank
@@ Property / cites work @@
+Optimal Designs for a Grouped Sequential Binomial Trial
+Normal rank